Position of FL receptor N-linked glycosylation sequons and sequence of B1-8 and Hy10 variants
| FL receptor . | B1-8 receptor variants . | Hy10 receptor variants . | ||||||
|---|---|---|---|---|---|---|---|---|
| . | Glycosylation . | Position . | Position . | Variant . | Sequence . | Position . | Variant . | Sequence . |
| A103HC | 62 NSS | FR3 | 33, CDR1/FR2 | B1-8 WT | WMH | 29, CDR1 | Hy10 WT | ITS |
| 106 NYS | CDR3 | W33N | NMS | I29N | NTS | |||
| A103 LC | 17 NVS | FR1 | W33Q | QMS | I29Q | QTS | ||
| A299 HC | 28NFT | CDR1 | W33N (control) | NMH | ||||
| 50 NIS | CDR2 | 100, CDR3 | B1-8 WT | DYY | ||||
| A299 LC | 107 NLT | FR4 | D100N | NDS | ||||
| A119 HC | 103 NDS | CDR3 | D100Q | QDS | ||||
| D100N (control) | NYY | |||||||
| FL receptor . | B1-8 receptor variants . | Hy10 receptor variants . | ||||||
|---|---|---|---|---|---|---|---|---|
| . | Glycosylation . | Position . | Position . | Variant . | Sequence . | Position . | Variant . | Sequence . |
| A103HC | 62 NSS | FR3 | 33, CDR1/FR2 | B1-8 WT | WMH | 29, CDR1 | Hy10 WT | ITS |
| 106 NYS | CDR3 | W33N | NMS | I29N | NTS | |||
| A103 LC | 17 NVS | FR1 | W33Q | QMS | I29Q | QTS | ||
| A299 HC | 28NFT | CDR1 | W33N (control) | NMH | ||||
| 50 NIS | CDR2 | 100, CDR3 | B1-8 WT | DYY | ||||
| A299 LC | 107 NLT | FR4 | D100N | NDS | ||||
| A119 HC | 103 NDS | CDR3 | D100Q | QDS | ||||
| D100N (control) | NYY | |||||||
FR, framework region; WT, wild-type.